Article

Medicare to Adjust Payment for Dialysis Drugs After Overspending Millions

The Medicare system is recalculating how much it will reimburse hospitals and clinics for the drugs used to treat dialysis patients after federal auditors found recently that the program could save as much as $880 million annually.

An analysis by The Washington Post in August showed that the government was overspending by hundreds of millions for just one group of those drugs.

Read the full story: http://wapo.st/Td5WnW

Source: The Washington Post

Related Videos
Crystal S. Denlinger, MD, FACP, CEO of the National Comprehensive Cancer Network
Ali Khawar
Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
Nancy Dreyer, MPH, PhD, FISE, chief scientific advisor to Picnic Health
Neil Goldfarb, CEO, Greater Philadelphia Business Coalition on Health
Screenshot of Mary Dunn, MSN, NP-C, OCN, RN, during a video interview
Seth Berkowitz, MD, MPH, associate professor of medicine, University of North Carolina at Chapel Hill
Related Content
what we're reading logo
July 26th 2024

What We’re Reading: Reproductive Health Interest; ADA Anniversary; Confidential Teen Contraception

AJMC Staff
The ending of the 2023 film “Barbie,” where she sees a gynecologist, has increased online search interest in gynecology; yesterday marked 34 years of the Americans With Disabilities Act (ADA); Texas Attorney General Ken Paxton is suing the Biden administration over Title X, a federal contraception program that provides teens birth control without parental consent.
Managed Care Cast: Frameworks for Advancing Health Equity
July 23rd 2024

Frameworks for Advancing Health Equity: Health Equity by Design

Giuliana Grossi
Melissa Clarke, MD, CMQ, the chief health equity officer at Elevance Health, explains "Health Equity by Design" and how Elevance Health is committed to ensuring a personalized and intentional approach for all its members.
What We're Reading logo
July 25th 2024

What We’re Reading: Abortion Pill Restrictions; Rising Infant Mortality Rate; Shot Provides HIV Protection

AJMC Staff
A federal appeals court ruled yesterday that a group of Republican-led states do not have legal standing to impose restrictions on the abortion pill mifepristone; the US infant mortality rate increased by 3% in 2022; a twice-yearly injection could prevent 100% of HIV infections.
Managed Care Cast logo
July 18th 2024

Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value

Brooke McCormick
On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
BeiGene Hopewell facility | Image credit: BeiGene
July 23rd 2024

BeiGene Opens $800M Flagship US Facility in New Jersey

Mary Caffrey
New Jersey Governor Phil Murphy joined BeiGene CEO John Oyler and about 300 guests to open the facility, located in Hopewell, New Jersey. Company officials said the new site will offer increased flexibility and supply chain diversity.
What We’re Reading: Social Media Regulations; Merck’s Antibody-Based RSV Vaccine; Drug Shortages Hit a New High
July 23rd 2024

What We’re Reading: Social Media Regulations; Merck’s Antibody-Based RSV Vaccine; Drug Shortages Continue

AJMC Staff
Efforts to regulate social media for youth face resistance; MK-1654 meets key goals in mid-to-late stage trial; active drug shortages remain above 300 for sixth consecutive quarter.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
CH LogoCenter for Biosimilars Logo